SAMANTHA MARTINEZ: Open Payments
NPI 1891209268 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,324 in 50 payments from 13 companies in 2025. Trend: 2023 $1,063 · 2024 $1,595 · 2025 $1,324
Food & beverage: $1,258Education: $34Consulting: $32
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $616 |
| GlaxoSmithKline, LLC. | 12 | $161 |
| GENZYME CORPORATION | 5 | $102 |
| Amgen Inc. | 4 | $95 |
| Pharming Healthcare, Inc. | 4 | $79 |
| CSL Behring | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| ADMA BioManufacturing LLC | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $26 |
Products named: AIRSUPRA, TEZSPIRE, NUCALA, DUPIXENT, FASENRA, RUCONEST, Andembry, NEFFY.
Industry payments across AZ — which companies pay providers there.
